Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik B Wilms

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Basic & Clinical Pharmacology & Toxicology|October 31, 2020
Sulpiride intoxication: Case report of a rare intoxicationSvenja Zonneveld, Adina Gawi, Erik B Wilms, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 19, 2021
Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controlsRenske van der Meer, Erik B Wilms, Richart Sturm, et al.
British Journal of Clinical Pharmacology|March 6, 2026
Pharmacokinetic drug-drug interactions with flucloxacillin and other isoxazolyl penicillins: A systematic literature review and practical guideJulia M Wortman, Emiel Leegwater, Erik B Wilms, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 16, 2015
[Post-injection syndrome after depot injection of olanzapine]Erik B Wilms, Marijke T van der Velden, Fred H van Essen, et al.
Pediatric Pulmonology|June 12, 2012
Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effectsErik B Wilms, Daniel J Touw, Harry G M Heijerman, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 1, 2015
[Auto-intoxication with an illegal slimming product]Bastiaan V C Kraaijenbrink, Hester L van den Hoek, Ralph J M Nowitzky, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the ProstateAnnemieke Sobels, Koen J Lentjes, Frank M J A Froeling, et al.
British Journal of Clinical Pharmacology|January 21, 2022
Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factorsEmiel Leegwater, Annette C Westgeest, Emile F Schippers, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2023
Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatmentJulia M Wortman, Emiel Leegwater, Daniëlle Van Lammeren-Venema, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 11, 2025
Adverse events to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis due to elevated drug exposure?: A case seriesSyendon B C Baromeo, Renske van der Meer, Richard C J M van Rossen, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Basic & Clinical Pharmacology & Toxicology|October 31, 2020
Sulpiride intoxication: Case report of a rare intoxicationSvenja Zonneveld, Adina Gawi, Erik B Wilms, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 19, 2021
Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controlsRenske van der Meer, Erik B Wilms, Richart Sturm, et al.
British Journal of Clinical Pharmacology|March 6, 2026
Pharmacokinetic drug-drug interactions with flucloxacillin and other isoxazolyl penicillins: A systematic literature review and practical guideJulia M Wortman, Emiel Leegwater, Erik B Wilms, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 16, 2015
[Post-injection syndrome after depot injection of olanzapine]Erik B Wilms, Marijke T van der Velden, Fred H van Essen, et al.
Pediatric Pulmonology|June 12, 2012
Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effectsErik B Wilms, Daniel J Touw, Harry G M Heijerman, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 1, 2015
[Auto-intoxication with an illegal slimming product]Bastiaan V C Kraaijenbrink, Hester L van den Hoek, Ralph J M Nowitzky, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the ProstateAnnemieke Sobels, Koen J Lentjes, Frank M J A Froeling, et al.
British Journal of Clinical Pharmacology|January 21, 2022
Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factorsEmiel Leegwater, Annette C Westgeest, Emile F Schippers, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2023
Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatmentJulia M Wortman, Emiel Leegwater, Daniëlle Van Lammeren-Venema, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 11, 2025
Adverse events to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis due to elevated drug exposure?: A case seriesSyendon B C Baromeo, Renske van der Meer, Richard C J M van Rossen, et al.
Pageof 5